duo-decadron
aché laboratórios farmacêuticos s.a - acetato de dexametasona, fosfato dissÓdico de dexametasona - glicocorticoides sistemicos
xtandi
astellas pharma europe b.v. - enzalutamida - neoplasias prostáticas - terapia endócrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
abba
sun farmacÊutica do brasil ltda - acetato de abiraterona - agentes antineoplÁsicos
acetato de abiraterona
dr. reddys farmacÊutica do brasil ltda - acetato de abiraterona - antineoplasico
acetato de abiraterona
sandoz do brasil indÚstria farmacÊutica ltda - acetato de abiraterona - outros antineoplasicos
acetato de abiraterona
sun farmacÊutica do brasil ltda - acetato de abiraterona - agentes antineoplÁsicos
lynparza comprimidos
astrazeneca do brasil ltda - olaparibe - outros agentes antineoplÁsicos
matiz
eurofarma laboratÓrios s.a. - acetato de abiraterona - antineoplasico
rarija
teva farmacÊutica ltda. - acetato de abiraterona - outros antineoplasicos
zytiga
janssen-cilag farmacÊutica ltda - acetato de abiraterona - outros antineoplasicos